Leveraging machine learning and genomics in target identification and validation to tackle complex disease mechanisms
25 Jun 2025
Target Identification
- How do we identify disease-driving, cell-specific targets that are associated with risk of disease progression (and not just risk of susceptibility)?
- Single target approaches do not suffice for complex diseases. How does one identify multiple-targets (two-, three- or more) for drugs?
- What are the different experimental models being used to generate data for target discovery (ranging from cell cultures to organdies to mouse models)? What are the strengths and limitations for each?
Industry Expert
